Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Clinical trial NCT05795400 · COMPLETED

Trial details

NCT number: NCT05795400
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction Heart Failure With Preserved Ejection Fraction Heart Failure With Mid Range Ejection Fraction Amyloid Cardiomyopathy

Start date: 2022-06-01
Primary completion: 2025-05-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.